Vous êtes ici: Home > J Cannabis Ther > Cannabis and the U.S. Controlled Substances Act

J Cannabis Ther 2001(1):095-109

Politics

Cannabis and the U.S. Controlled Substances Act

Author
J. Gettman

Abstract
The scheduling of cannabis under the Controlled Substances Act (CSA) has established legal precedents that determine how scientific evidence affects its regulation in the United States. This background challenges three common fallacies that make it seem marijuana prohibition is the only viable policy outcome. A contemporary effort to reschedule cannabis is based on recent findings that have established that marijuana lacks the high potential for abuse required for Schedule I or Schedule II status under the CSA. The primary policy issue is not, then, whether marijuana is the best medicine but instead whether people who use it medically should be treated as criminals.


Keywords
Cannabis, cannabis use, cannabinoids, marijuana, marijuana use, tetrahydrocannabinol, dronabinol, drug control, drug policy, marijuana laws

Texte intégral au format PDF ]

Déclaration

Déclaration des Droits de l’Homme en faveur de l’accès médical au cannabis et aux cannabinoïdes

Indica

A new article in Cannabinoids by Jacob Erkelens and Arno Hazekamp on Cannabis Indica.

Conférence IACM 2013

7th Conference on Cannabinoids in Medicine



Photos  
Videos online
Abstract book

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.